Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.

@article{Smith2002ClubDM,
  title={Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.},
  author={Kelly M. Smith and Lisa L Larive and Frank Romanelli},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2002},
  volume={59 11},
  pages={
          1067-76
        }
}
  • Kelly M. Smith, L. L. Larive, F. Romanelli
  • Published 1 June 2002
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
The abuse of methylenedioxymethamphetamine (MDMA), flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate (GHB) is discussed. Club drugs are chemical substances used recreationally in social settings. Use is increasingly frequent among young people, especially during all-night dance parties. All four agents have been classified as controlled substances. MDMA ("ecstasy") is available as a tablet, a capsule, and a powder; formulations may contain many adulterants. MDMA increases the… Expand
Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
TLDR
Club drugs are substances commonly used at nightclubs, music festivals, raves, and dance parties to enhance social intimacy and sensory stimulation, and there are no specific antidotes except for flunitrazepam, a benzodiazepine that responds to flumazenil. Expand
[Club drugs].
TLDR
The purpose of this article is creating in Portuguese language a knowledge data base on club drugs, that health professionals of various specialties can use as a reference when dealing with individual with this kind of drug abuse. Expand
MDMA and Other “Club Drugs”
The use of the club drugs 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”), gamma-hydroxybutyrate (GHB), flunitrazepam (Rohypnol), ketamine and LSD is a popular practice among young peopleExpand
The γ-Hydroxybutyrate Withdrawal Syndrome
TLDR
Although many GHB users will experience a mild withdrawal syndrome upon drug discontinuation, those with chronic heavy GHB use can experience severe withdrawal, and patients with fulminant GHB withdrawal require aggressive treatment with cross-tolerant sedative hypnotics, such as benzodiazepines. Expand
A New Psychoactive Substance, Gamma Hydroxybutyrate (GHB): A Case Report.
  • H. Bulut
  • Medicine
  • Noro psikiyatri arsivi
  • 2019
TLDR
In order to prevent the use of GHB, it would be appropriate to develop psycho-education methodologies, establish legislative regulations, and include GHB tests in substance screening analyses. Expand
Sedative‐Hypnotic Agents That Impact Gamma‐Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma‐Hydroxybutyric Acid, Phenibut, and Selank
TLDR
There are many nonopioid central nervous system depressant substances that share a gamma‐aminobutyric acid (GABA) receptor–related mechanism of action that are used to treat anxiety, seizures, depression, and insomnia but are also used as substances of abuse and used to facilitate sexual assault. Expand
Flunitrazepam–Membrane Binding
Abstract Flunitrazepam (FNZ) is a sedative–hypnotic benzodiazepine with important therapeutic usefulness and significant abuse liability. Its capability to induce anterograde amnesia favors FNZ useExpand
An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers
TLDR
It is suggested that flunitrazepam may have a greater abuse liability than triazolam, and that this abuse liability difference emerges on measures taken 24 h after drug administration but not on same-day measures. Expand
Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
TLDR
It is reported that ingestion of foxy by a healthy 23-year-old man that resulted in rhabdomyolysis and transient acute renal failure. Expand
Anesthetic implications of acute methylenedioxymethamphetamine intoxication in a patient with traumatic intracerebral hemorrhage.
TLDR
A case report of traumatic subarachnoid hemorrhage in a patient with acute MDMA intoxication and a review of the anesthetic implications are presented. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 57 REFERENCES
MDMA (ecstasy) and the rave: a review.
TLDR
MDMA is a “designer” drug that is becoming popular with American adolescents at dance halls known as “raves” and on college campuses, and an analogue of amphetamine, which shares properties with both amphetamine and hallucinogenic drugs. Expand
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
TLDR
Improved recognition of MDMA-related syndromes is hoped to provide insight into the function of serotonin in the human brain, in health as well as disease. Expand
Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use.
TLDR
Observations of the prevalence of MDMA involvement in cases of reckless driving and the MDMA blood concentrations measured indicate a risk increase comparable to that observed after use of amphetamines. Expand
Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial
TLDR
The acute cardiovascular effects of oral MDMA are measured to compare these effects with those of a well-characterized cardiostimulant, the -agonist dobutamine to improve prediction of and intervention in cases of MDMA cardiotoxicity. Expand
Amphetamine designer drugs - an overview and epidemiology.
TLDR
The methylenedioxy-derivatives of amphetamine and methamphetamine represent the largest group of designer drugs, and a number of related compounds have been synthesised, including derivatives with one or more substituents attached at different positions to the phenylring of Amphetamine or methamphetamine. Expand
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
TLDR
These data indicate that N-methyl-D-aspartate antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states. Expand
Acute poisoning from gamma-hydroxybutyrate in California.
TLDR
GHB is a putative neurotransmitter marketed as a growth hormone releaser for bodybuilders and, despite being banned by the US Food and Drug Administration, GHB is still widely available in the underground drug market. Expand
Abuse and therapeutic potential of gamma-hydroxybutyric acid.
TLDR
Gamma-hydroxybutyric acid has established efficacy as an anesthetic agent, and preliminary evidence supports its utility in the treatment of alcohol dependence, opiate dependence, and narcolepsy. Expand
Cerebral oedema after ingestion of MDMA (“ecstasy”) and unrestricted intake of water
TLDR
Two patients who developed clinical effects due to the syndrome of inappropriate secretion of antidiuretic hormone after ingestion of MDMA are reported on. Expand
A Tale of Novel Intoxication: A Review of the Effects of γ-hydroxybutyric Acid With Recommendations for Management.
TLDR
Emergency physicians are urged to become familiar with GHB because of its potential for severe morbidity, as well as its potential use as a future resuscitative agent, and recommendations for management of acute GHB intoxication. Expand
...
1
2
3
4
5
...